Source:http://linkedlifedata.com/resource/pubmed/id/17082326
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
2
|
| pubmed:dateCreated |
2007-1-29
|
| pubmed:abstractText |
Starting from the 2.8-A resolution x-ray structure of bovine rhodopsin, three-dimensional molecular models of the complexes between arginine vasopressin and two receptor subtypes (V1a, V1b) have been built. Amino acid sequence alignment and docking studies suggest that four key residues (1.35, 2.65, 4.61, and 5.35) fine tune the binding of vasopressin and related peptide agonists to both receptor subtypes. To validate these predictions, a series of single or double mutants were engineered at V1a and V1b receptor subtypes and tested for their binding and functional properties. Two negatively charged amino acids at positions 1.35 and 2.65 are key anchoring residues to the Arg8 residue of arginine vasopressin. Moreover, two amino acids (V(4.61) and P(5.35)) delineating a hydrophobic subsite at the human V1b receptor are responsible for the recognition of V1b selective peptide agonists. Last, one of the latter positions (5.35) is hypothesized to explain the pharmacological species differences between rat and human vasopressin receptors for a V1b peptide agonist. Altogether these refined three-dimensional models of V1a and V1b human receptors should enable the identification of further new selective V1a and V1b agonists as pharmacological but also therapeutic tools.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Feb
|
| pubmed:issn |
0888-8809
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
21
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
512-23
|
| pubmed:meshHeading |
pubmed-meshheading:17082326-Amino Acid Sequence,
pubmed-meshheading:17082326-Animals,
pubmed-meshheading:17082326-Arginine Vasopressin,
pubmed-meshheading:17082326-Binding Sites,
pubmed-meshheading:17082326-CHO Cells,
pubmed-meshheading:17082326-Cattle,
pubmed-meshheading:17082326-Cricetinae,
pubmed-meshheading:17082326-Cricetulus,
pubmed-meshheading:17082326-Humans,
pubmed-meshheading:17082326-Models, Molecular,
pubmed-meshheading:17082326-Molecular Sequence Data,
pubmed-meshheading:17082326-Mutation,
pubmed-meshheading:17082326-Protein Conformation,
pubmed-meshheading:17082326-Protein Interaction Mapping,
pubmed-meshheading:17082326-Radioligand Assay,
pubmed-meshheading:17082326-Rats,
pubmed-meshheading:17082326-Receptors, Vasopressin,
pubmed-meshheading:17082326-Sequence Homology, Amino Acid
|
| pubmed:year |
2007
|
| pubmed:articleTitle |
Mapping the binding site of arginine vasopressin to V1a and V1b vasopressin receptors.
|
| pubmed:affiliation |
Bioinformatics of the Drug, Centre Nationale de la Recherche Scientifique Université Louis Pasteur (CNRS-ULP), Unité Mixte de Recherche 7175-LC1, 74 Route du Rhin, F-67401 Illkirch, France.
|
| pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|